Literature DB >> 2321174

Immunosuppression by pulmonary surfactant: mechanisms of action.

M L Wilsher1, D J Parker, P L Haslam.   

Abstract

Pulmonary surfactant has been shown by this group to suppress peripheral blood lymphocyte responses to mitogens and alloantigens in a dose dependent manner, though the mechanism of action of the suppressive effect is not clearly understood. To try to clarify this, attempts were made to reverse the effects of preincubation with surfactant, obtained by bronchoalveolar lavage from pigs, on lymphocytes and accessory monocytes obtained from the blood of normal volunteers, by washing and incubating the cells in medium alone for various periods up to 24 hours. Immunosuppression, measured as the reduction in thymidine incorporation in response to the mitogen phytohaemagglutinin, could not be reversed by these methods. The addition of indomethacin (up to 100 micrograms/ml for 72 hours) also had no effect, indicating that the immunosuppression was not related to synthesis of prostaglandins. Incubation with surfactant for as little as two hours before addition of mitogen suppressed in vitro lymphoproliferative responses by half, but surfactant added two hours after mitogen had no observed effect. Preincubation of purified lymphocytes in surfactant, before they were cultured with accessory monocytes and mitogen, caused significant suppression of response, but preincubation of purified monocytes had no suppressive effect. There was no change in the intensity of HLA-DR expression on monocytes. These results support the hypothesis that surfactant exerts its effects on the resting uncommitted lymphocyte rather than on antigen presenting monocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2321174      PMCID: PMC475629          DOI: 10.1136/thx.45.1.3

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  23 in total

1.  Serum HIV antigen and anti-P24-antibodies in 200 HIV seropositive patients: correlation with CD4 and CD8 lymphocyte subsets.

Authors:  J M Andrieu; D Eme; A Venet; C Audroin; J M Tourani; M Stern; D Israel-Biet; K Beldjord; F Driss; P Even
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

2.  Spectrum of immunoregulatory functions and properties of human alveolar macrophages.

Authors:  E A Rich; D J Tweardy; H Fujiwara; J J Ellner
Journal:  Am Rev Respir Dis       Date:  1987-08

3.  The effect of pulmonary surface-active material on the generation and expression of murine B- and T-lymphocyte effector functions in vitro.

Authors:  R G Sitrin; M J Ansfield; H B Kaltreider
Journal:  Exp Lung Res       Date:  1985       Impact factor: 2.459

Review 4.  Surfactant for the treatment of respiratory distress syndrome.

Authors:  A Jobe; M Ikegami
Journal:  Am Rev Respir Dis       Date:  1987-11

Review 5.  The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function.

Authors:  C D Stubbs; A D Smith
Journal:  Biochim Biophys Acta       Date:  1984-01-27

6.  Rat lung lavage surfactant enhances bacterial phagocytosis and intracellular killing by alveolar macrophages.

Authors:  S O'Neill; E Lesperance; D J Klass
Journal:  Am Rev Respir Dis       Date:  1984-08

7.  The role of accessory cells in polyclonal T cell activation II. Induction of interleukin 2 responsiveness requires cell-cell contact.

Authors:  T Hünig
Journal:  Eur J Immunol       Date:  1983-07       Impact factor: 5.532

8.  Human alveolar macrophages: HLA-DR-positive macrophages that are poor stimulators of a primary mixed leukocyte reaction.

Authors:  M F Lipscomb; C R Lyons; G Nunez; E J Ball; P Stastny; W Vial; V Lem; J Weissler; L M Miller
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

9.  Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes.

Authors:  L Davis; P E Lipsky
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

10.  Effect of exogenous lipids and lipoproteins on the primary immune response in vitro.

Authors:  T E Shine; J R Little; V Shore; G Medoff; A Abegg
Journal:  Eur J Immunol       Date:  1980-09       Impact factor: 5.532

View more
  9 in total

1.  In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases.

Authors:  C Prior; P L Haslam
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

2.  Surfactant prevents quartz induced down-regulation of complement receptor 1 in human granulocytes.

Authors:  G Zetterberg; J Lundahl; T Curstedt; A Eklund
Journal:  Inflammation       Date:  1997-02       Impact factor: 4.092

3.  Aberrant lung remodeling in a mouse model of surfactant dysregulation induced by modulation of the Abca3 gene.

Authors:  Michael F Beers; Lars Knudsen; Yaniv Tomer; Julian Maronn; Ming Zhao; Matthias Ochs; Surafel Mulugeta
Journal:  Ann Anat       Date:  2016-12-26       Impact factor: 2.698

4.  CD36-Mediated Uptake of Surfactant Lipids by Human Macrophages Promotes Intracellular Growth of Mycobacterium tuberculosis.

Authors:  Claire E Dodd; Charlie J Pyle; Rebecca Glowinski; Murugesan V S Rajaram; Larry S Schlesinger
Journal:  J Immunol       Date:  2016-11-09       Impact factor: 5.422

5.  Protective role of the lung collectins surfactant protein A and surfactant protein D in airway inflammation.

Authors:  Angela Haczku
Journal:  J Allergy Clin Immunol       Date:  2008-11       Impact factor: 10.793

Review 6.  SP-D and regulation of the pulmonary innate immune system in allergic airway changes.

Authors:  L R Forbes; A Haczku
Journal:  Clin Exp Allergy       Date:  2010-04       Impact factor: 5.018

7.  Lysophosphatidylcholine abrogates the CR1 preserving effect of surfactant on quartz-exposed human granulocytes.

Authors:  G Zetterberg; T Curstedt; J Lundahl; A Eklund
Journal:  Inflammation       Date:  1999-04       Impact factor: 4.092

8.  Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes.

Authors:  Markus Fehrholz; Kirsten Glaser; Silvia Seidenspinner; Barbara Ottensmeier; Tore Curstedt; Christian P Speer; Steffen Kunzmann
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

Review 9.  The surfactant system of the adult lung: physiology and clinical perspectives.

Authors:  H Hamm; H Fabel; W Bartsch
Journal:  Clin Investig       Date:  1992-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.